ReviewClinicoEconomics and outcomes research : CEOR2019
Management Of Glaucoma In Developing Countries: Challenges And Opportunities For Improvement.
Review in ClinicoEconomics and outcomes research : CEOR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Glaucoma management across 13 countries in Central, Eastern and Southeastern Europe: an exploratory survey.International ophthalmology · 2026Article
- Glaucoma burden in the Western Pacific Region from 1990 to 2023: country-level disparities, demographic drivers, and metabolic risk attribution.International ophthalmology · 2026Observational
- Article
- Sociodemographic and Clinical Determinants of Glaucoma in a Sub-Saharan African Population: A Case-Control Study.Health science reports · 2026Article
- Development of deep learning model to screen for primary open-angle glaucoma in African ancestry individuals.NPJ digital medicine · 2026Article
- A window into vision health: quality of life and satisfaction among glaucoma patients.International ophthalmology · 2025Article
- Glaucoma prevalence and treatment in sub-Saharan Africa's elderly population: a scoping review.BMC geriatrics · 2025Article
- Diagnostic accuracy of the TsiogkaSpaeth grid test for detecting visual field defects in patients with glaucoma.BMJ open ophthalmology · 2025Article
- Lived experiences and coping strategies of people living with Glaucoma in Nigeria: A qualitative study.PloS one · 2025Article
- Evaluation of an offline, artificial intelligence system for referable glaucoma screening using a smartphone-based fundus camera: a prospective study.Eye (London, England) · 2024Article
- Advancing Glaucoma Care: Integrating Artificial Intelligence in Diagnosis, Management, and Progression Detection.Bioengineering (Basel, Switzerland) · 2024Review
- Factors limiting glaucoma care among glaucoma patients in Nigeria: A scoping review.PLOS global public health · 2024Article
- Risk factors associated with elevated intraocular pressure: a population-based study in a rural community of Bangladesh.BMJ open ophthalmology · 2023Article
- Online circular contrast perimetry via a web-application: optimising parameters and establishing a normative database.Eye (London, England) · 2023Article
- From the past to the present, optical coherence tomography in glaucoma: a practical guide to a common disease.F1000Research · 2023Review
- Challenges in Managing Secondary Glaucoma Post-Repeat Penetrating Keratoplasty in a Developing Country.International medical case reports journal · 2023Article
- [Knowledge, attitudes and practices related to cataract and glaucoma in the population of Conakry, Guinea].The Pan African medical journal · 2022Article
- Outcomes after combined excisional goniotomy and manual small incision cataract surgery.International journal of ophthalmology · 2022Article
- Acceptance of a Smartphone-Based Visual Field Screening Platform for Glaucoma: Pre-Post Study.JMIR formative research · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Glaucoma is the leading cause of blindness in the developed and developing world. Not only is the clinical impact of this disease considerable, but associated economic and humanistic burdens - affecting patients, caregivers, and society - are substantial. Since glaucoma is an age-related disorder and populations in many developing countries are aging at a faster pace than in the developed world, increasing attention is being focused on ways to ameliorate the burdens of illness. In this paper, we examine the burdens of glaucoma with particular focus on developing countries, discuss some of the challenges that exist in delivering optimal glaucoma management within budget constraints, and bring into perspective how we could improve current healthcare systems, leverage technology, and strike an appropriate balance between cost and quality of care, thereby offering considerations to payors and policymakers in these countries that may result in longer-term cost savings, while concurrently striving to achieve the WHO Vision on the prevention of blindness and visual impairment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.